Literature DB >> 6956259

Effects of specific antibodies on the interaction between the fungus Candida albicans and human oral mucosa.

J B Epstein, L H Kimura, T W Menard, E L Truelove, N N Pearsall.   

Abstract

Host-parasite interactions were studied in four groups: non-infected controls; infected carriers of Candida albicans without evidence of candidiasis; subjects with acute candidiasis; and subjects with chronic candidiasis. Specific anti-candida antibodies were demonstrated in saliva from subjects of all four groups; the titres reflected the degree of antigenic stimulation, being significantly higher in candidiasis than in controls or infected carriers. The adherence of C. albicans to buccal epithelial cells was not significantly different in a given saliva, regardless of whether the assay was carried out with autologous C. albicans and epithelial cells or with a stock strain in a standardized assay. Therefore, the standard assay was used to study the effects of specific salivary antibodies on adherence. A significant inverse correlation was found between salivary IgA anti-candida antibodies and the adherence of C. albicans to buccal epithelial cells, suggesting that IgA antibodies can inhibit adherence of candida to the oral mucosa. In some instances, removal of antibodies led to a significant increase in adherence; however, often this was not the case, indicating that some but not all of the antibodies present were capable of inhibiting the adherence of C. albicans to epithelial cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6956259     DOI: 10.1016/0003-9969(82)90086-3

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  11 in total

Review 1.  Antibody immunity and invasive fungal infections.

Authors:  A Casadevall
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

2.  Immunoglobulin A1 and A2 subclass of salivary antibodies to Candida albicans in patients with oral candidosis.

Authors:  S Jeganathan; D Ufomata; J A Hobkirk; L Ivanyi
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

Review 3.  Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.

Authors:  Louis de Repentigny; Daniel Lewandowski; Paul Jolicoeur
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

4.  Factors influencing the expression in vitro of Candida albicans stress mannoproteins reactive with salivary secretory IgA.

Authors:  V Vidotto; L Polonelli; S Conti; J Pontón; I Vieta
Journal:  Mycopathologia       Date:  1998       Impact factor: 2.574

Review 5.  The role of Candida albicans secreted aspartic proteinase in the development of candidoses.

Authors:  L Hoegl; M Ollert; H C Korting
Journal:  J Mol Med (Berl)       Date:  1996-03       Impact factor: 4.599

6.  A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities.

Authors:  María D Moragues; Miren J Omaetxebarria; Natalia Elguezabal; María J Sevilla; Stefania Conti; Luciano Polonelli; José Pontón
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

7.  Retrovirus-induced immunodeficiency in mice exacerbates gastrointestinal candidiasis.

Authors:  G T Cole; K Saha; K R Seshan; K T Lynn; M Franco; P K Wong
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

8.  Immunoglobulin A (IgA), IgA1, and IgA2 antibodies to Candida albicans in whole and parotid saliva in human immunodeficiency virus infection and AIDS.

Authors:  M M Coogan; S P Sweet; S J Challacombe
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

Review 9.  Mucosal immunity and Candida albicans infection.

Authors:  David L Moyes; Julian R Naglik
Journal:  Clin Dev Immunol       Date:  2011-06-23

Review 10.  Immunology of oral candidiasis.

Authors:  Janardhanam Dineshshankar; Muniapillai Sivakumar; M Karthikeyan; P Udayakumar; K T Shanmugam; G Kesavan
Journal:  J Pharm Bioallied Sci       Date:  2014-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.